BGLU13 Antibody

Shipped with Ice Packs
In Stock

Description

General Antibody Structure and Function

Antibodies (immunoglobulins) are Y-shaped proteins produced by B cells to neutralize pathogens like bacteria and viruses . Key features include:

  • Structure: Composed of two heavy chains and two light chains, forming antigen-binding fragments (Fab) and a crystallizable fragment (Fc) .

  • Function: Neutralize pathogens, agglutinate foreign cells, activate complement systems, and recruit immune cells .

  • Classes: IgG, IgM, IgA, IgE, and IgD, each with distinct roles in immunity .

BGLU13: Beta-Glucosidase 13

BGLU13 is a plant enzyme encoded by the AT5G44640 gene in Arabidopsis thaliana. It belongs to the beta-glucosidase family, which hydrolyzes glycosidic bonds in carbohydrates .

AttributeDescription
Gene IDAT5G44640
Protein NameBeta-glucosidase 13
OrganismArabidopsis thaliana (Mouse-ear cress)
FunctionCarbohydrate metabolism, cell wall modification, and stress response
Database ReferencesThaleMine , UniProtKB

No studies in the provided sources describe antibodies targeting BGLU13. Research on plant enzymes like BGLU13 typically focuses on their biochemical roles rather than therapeutic antibody development.

Antibody Characterization and Challenges

Antibody research faces reproducibility challenges due to insufficient validation . For example:

  • Validation Standards: Only ~50–75% of commercial antibodies perform reliably in specific applications .

  • Recombinant Antibodies: Outperform monoclonal/polyclonal antibodies in assays due to higher specificity .

Antibody Engineering Innovations

Recent advances include:

  • Bispecific Antibodies: Target two epitopes (e.g., ACE910 for hemophilia A) .

  • Cell-Penetrating Antibodies: Modified with phosphorothioated DNA for intracellular delivery .

  • Neutralizing Antibodies: E.g., Evusheld (tixagevimab/cilgavimab) for COVID-19 prophylaxis .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
BGLU13 antibody; At5g44640 antibody; K15C23.9 antibody; Beta-glucosidase 13 antibody; AtBGLU13 antibody; EC 3.2.1.21 antibody
Target Names
BGLU13
Uniprot No.

Q&A

Basic Research Questions

How do I experimentally validate BGLU13 antibody specificity in plant flavonoid metabolism studies?

  • Method: Use a multi-step validation workflow:

    • Western blot: Compare protein extracts from wild-type and bglu13 knockout mutants (e.g., T-DNA insertion lines) to confirm antibody binding specificity .

    • Enzyme activity assays: Measure hydrolysis of flavonol 3-O-β-glucosides (e.g., quercetin 3-O-β-glucoside) in cell-free extracts using HPLC-DAD or UHPLC-DAD-MSn .

    • Immunolocalization: Pair with fluorescent tags to track BGLU13 spatial expression in plant tissues under stress conditions (e.g., low-temperature recovery) .

What are the primary applications of BGLU13 antibodies in plant biochemistry?

  • Key applications:

    • Quantifying BGLU13 protein levels during abiotic stress responses (e.g., cold acclimation) .

    • Investigating substrate specificity through competitive inhibition assays with structurally similar glycosides .

    • Validating RNAi or CRISPR-mediated gene silencing in metabolic engineering studies .

Advanced Research Challenges

How to resolve contradictions in BGLU13 functional data across plant species?

  • Approach:

    • Phylogenetic analysis: Compare BGLU13 protein sequences across species (e.g., Arabidopsis vs. rice) to identify conserved domains .

    • Cross-species complementation: Express rice BGLU13 in Arabidopsis bglu13 mutants to test functional conservation .

    • Substrate profiling: Use recombinantly expressed BGLU13 with diverse flavonoid glycosides (Table 1) .

Table 1: Substrate specificity profile of recombinant BGLU13

SubstrateHydrolysis Efficiency (%)Reference
Quercetin 3-O-β-glucoside92 ± 3.1
Kaempferol 3-O-β-glucoside78 ± 4.5
Rutin (quercetin rutinoside)<5

What experimental controls are critical when studying BGLU13 knockout phenotypes?

  • Essential controls:

    • Genetic: Include complemented lines (e.g., bglu13 mutants expressing native BGLU13).

    • Biochemical: Test for off-target hydrolysis using bglu15 mutants to rule out functional redundancy .

    • Environmental: Standardize growth conditions (light, temperature) due to BGLU13's role in stress responses .

How to design a robust protocol for BGLU13 antibody-based protein quantification?

  • Protocol optimization:

    • Extraction buffer: Use 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and protease inhibitors .

    • Normalization: Include reference proteins (e.g., Rubisco activase) to account for tissue-specific variation .

    • Cross-reactivity test: Validate against other GH1 family enzymes (e.g., BGLU12, BGLU17) .

Methodological Considerations

What advanced techniques complement BGLU13 antibody studies in metabolic flux analysis?

  • Integrated workflow:

    • Isotope tracing: Use 13C^{13}\text{C}-labeled flavonoid precursors to track metabolic redistribution in mutants .

    • Multi-omics: Pair antibody-based protein quantification with RNA-seq and LC-MS metabolomics .

    • Structural modeling: Perform homology modeling of BGLU13 active sites using AlphaFold2 to predict substrate interactions .

How to address inconsistent BGLU13 antibody performance across plant developmental stages?

  • Troubleshooting strategies:

    • Epitope mapping: Verify antibody recognition of conserved regions (e.g., residues 120-150 in rice BGLU13) .

    • Post-translational modification (PTM) analysis: Check for phosphorylation/N-glycosylation that may mask epitopes .

    • Temporal sampling: Collect tissues at multiple time points (e.g., pre-/post-flowering) to account for expression dynamics .

What statistical methods are recommended for analyzing BGLU13 knockdown/overexpression data?

  • Analysis framework:

    • Mixed-effects models: Account for batch effects in multi-experiment datasets.

    • Pathway enrichment: Use MapMan or KEGG to identify perturbed metabolic networks .

    • Multivariate regression: Correlate BGLU13 protein levels with flavonoid catabolite concentrations .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.